Sanofi Is Now the Third Insulin Producer to Slash Prices

Sanofi will cut the U.S. list price of two of its insulins, making it the third…

Sanofi cuts list price on Lantus insulin by 78% in the U.S.

Sanofi cuts list price on Lantus insulin by 78% in the U.S. Source link

Sanofi to cut US price of its most-prescribed insulin by 78%

Sanofi SA said on Thursday it will cut US list prices for its most-prescribed insulin product,…

Facing political pressure, Sanofi follows Eli Lilly and Novo Nordisk in slashing insulin prices

A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a…

Sanofi hones in on type 1 diabetes in $2.9 billion Provention Bio deal By Reuters

© Reuters. FILE PHOTO: A logo on the Sanofi exhibition space at the Viva Technology conference…

Sanofi head of R&D to depart; eyes launch of 2 new drugs for hemophilia, RSV in 2023

Sanofi head of R&D to depart; eyes launch of 2 new drugs for hemophilia, RSV in…

Sanofi puts brakes on phase 3 trials of myasthenia gravis candidate tolebrutinib

Sanofi puts brakes on phase 3 trials of myasthenia gravis candidate tolebrutinib Source link

JIMMIE ALLEN AND FAMILY PARTNER WITH SANOFI TO SPREAD AWARENESS ABOUT RSV

Jimmie Allen is teaming up with Sanofi to spread awareness about Respiratory Syncytial Virus (RSV). The…